These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 24948144)

  • 1. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
    Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of low bone mass in CKD-5D patients.
    Blomquist GA; Davenport DL; Mawad HW; Monier-Faugere MC; Malluche HH
    Clin Nephrol; 2016 Feb; 85(2):77-83. PubMed ID: 26587778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E; Okuno S; Ichii M; Norimine K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC; Ma WY; Yu JC; Wu CC; Chu P
    Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.
    Jódar Gimeno E; Muñoz-Torres M; Escobar-Jiménez F; Quesada Charneco M; Luna del Castillo JD; Oleà N
    Calcif Tissue Int; 1997 Nov; 61(5):370-6. PubMed ID: 9351877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mass, biochemical markers and growth in children with chronic kidney disease: a 1-year prospective study.
    Swolin-Eide D; Magnusson P; Hansson S
    Acta Paediatr; 2007 May; 96(5):720-5. PubMed ID: 17381473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
    Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease.
    Lalayiannis AD; Crabtree NJ; Ferro CJ; Askiti V; Mitsioni A; Biassoni L; Kaur A; Sinha MD; Wheeler DC; Duncan ND; Popoola J; Milford DV; Long J; Leonard MB; Fewtrell M; Shroff R
    Nephrol Dial Transplant; 2021 Sep; 36(10):1872-1881. PubMed ID: 33094322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function and bone mineral density in community-dwelling elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study.
    Fujita Y; Iki M; Tamaki J; Kouda K; Yura A; Kadowaki E; Sato Y; Moon JS; Tomioka K; Okamoto N; Kurumatani N
    Bone; 2013 Sep; 56(1):61-6. PubMed ID: 23684959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients.
    Fujimori A; Okada S; Sakai M; Tome K; Fukagawa M
    Nephron Clin Pract; 2011; 118(4):c375-9. PubMed ID: 21325869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K; Gut P; Sowińska A; Ruchała M; Fichna M
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
    Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
    BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study.
    Kuo TH; Lin WH; Chao JY; Wu AB; Tseng CC; Chang YT; Liou HH; Wang MC
    BMC Nephrol; 2019 Jul; 20(1):266. PubMed ID: 31315601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in bone mass and bone turnover following distal forearm fracture.
    Ingle BM; Hay SM; Bottjer HM; Eastell R
    Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.